Ligand validation:4QR7

MLD: GLCNAC(BETA1-4)-MURNAC(1,6-ANHYDRO)-L-ALA-GAMMA-D-GLU-MESO-A2PM-D-ALA

MLD is a Ligand Of Interest in 4QR7 designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
4QR7_MLD_A_501	7%	3%	0.264	0.753	1.54	4.38	9	30	11	0	84%	0.8438
4QTF_MLD_A_501	3%	11%	0.267	0.668	1.62	2.53	8	23	0	0	72%	0.7188
4QRB_MLD_A_501	2%	5%	0.251	0.539	1.75	3.39	14	29	3	0	77%	0.7656
2CB3_MLD_D_1344	63%	15%	0.137	0.932	1.68	2.04	9	20	0	0	100%	1
7NT0_MLD_BBB_302	60%	50%	0.092	0.959	0.89	1.04	2	2	2	0	55%	0.5469
6TOP_MLD_D_701	11%	74%	0.217	0.828	0.34	0.67	-	-	0	0	50%	0.5

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.